It is hard to get excited after looking at Merck's (NYSE:MRK) recent performance, when its stock has declined 13% ...

Societe Generale has recently reduced Merck & Co Inc (MRK) stock to Sell rating, as announced on March 11, 2024, according to Finviz. Earlier, on January 4, 2024, TD Cowen had raised the stock from a ...

The European drugs regulator said on Friday it was reviewing anti hair-loss drugs, including Organon's Propecia and its ...

Shares of Merck & Co. Inc. MRK slipped 0.37% to $109.77 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.90% to 5,751.07 and ...

Summit Therapeutics (NASDAQ: SMMT). This California-based biotech is developing a cancer medicine that has produced excellent ...

Ethereum, or 1 ETH, traded at $2,385.83 as of 8 a.m. ET. The highest intraday price the cryptocurrency reached in the past ...

Summit Therapeutics Inc. may have a potential successor to Merck's Keytruda with strong clinical data from China, but awaits ...

U.S. stock markets closed lower on Thursday after a choppy session. Market participants were mostly remained sidelined before the release of the key job data for September. Crude oil prices spiked ...

European regulators are considering withdrawing market authorizations for certain hair loss and enlarged prostate treatments, ...

CAPACITI, a tech career accelerator, launches a new satellite hub in Hazyview, Mpumalanga, in partnership with Good Work ...

An analysis of Q3 layoffs in pharmaceutical and biotech companies shows a decline in numbers as the summer progressed. Read ...

Thermo Fisher's Greenville facility, one of the largest in the U.S., has faced repeated FDA regulatory violations. Key concerns include contamination prevention and inadequate equipment sterilization ...